Company / Net Income
Kura Oncology, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$278.7M
FY2025
5-year range
-$278.7M / -$130.5M
FY2021-FY2025
Trend
-60.2%
vs FY2024
Sector context
#174 of 216
Health Care
What the data says
Kura Oncology, Inc.'s net income of -$279M is lower than 81% of companies in the Health Care sector (FY2025). Net Income has declined for 9 consecutive years, from -$28M in FY2016 to -$279M in FY2025.
Based on SEC 10-K filings.
-$279M in FY2025.
Declined from -$153M to -$279M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 216This company -$278.7M Sector average $454.3M
▼
-161.3% below sector average
Key checks
Key Insights
- Kura Oncology, Inc.'s net income has declined for 9 consecutive years.
- In FY2025, net income decreased 60.2% year-over-year.
- Ranks #174 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$278.7M | -60.2% |
| FY2024 | -$174.0M | -14.0% |
| FY2023 | -$152.6M | -12.4% |
| FY2022 | -$135.8M | -4.1% |
| FY2021 | -$130.5M | -45.6% |
| FY2020 | -$89.6M | -41.9% |
| FY2019 | -$63.1M | -4.5% |
| FY2018 | -$60.4M | -70.6% |
| FY2017 | -$35.4M | -28.6% |
| FY2016 | -$27.6M | -21.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026